Literature DB >> 17274213

Effectiveness of transcendental meditation on functional capacity and quality of life of African Americans with congestive heart failure: a randomized control study.

Ravishankar Jayadevappa1, Jerry C Johnson, Bernard S Bloom, Sanford Nidich, Shashank Desai, Sumedha Chhatre, Donna B Raziano, Robert Schneider.   

Abstract

OBJECTIVE: To evaluate the effectiveness of a Transcendental Meditation (TM) stress reduction program for African Americans with congestive heart failure (CHF).
DESIGN: Randomized, controlled study PARTICIPANTS AND INTERVENTION: We recruited 23 African American patients > or = 55 years of age who were recently hospitalized with New York Heart Association class II or III CHF and with an ejection fraction of < .40. Participants were randomized to either TM or health education (HE) group. MAIN OUTCOME MEASURES: Primary outcome measure was six-minute walk test; secondary outcomes were generic and disease-specific health-related quality of life, quality of well being, perceived stress, Center for Epidemiologic Studies Depression Scale (CES-D), rehospitalizations, brain natriuretic peptide, and cortisol. Changes in outcomes from baseline to three and six months after treatment were analyzed by using repeated measures analysis of variance, covarying for baseline score.
RESULTS: For the primary outcome of functional capacity, the TM group significantly improved on the six-minute walk test from baseline to six months after treatment compared to the HE group (P = .034). On the secondary outcome measures, the TM group showed improvements in SF-36 subscales and total score on the Minnesota Living with Heart Failure scale. On the CES-D, the TM group showed significant decrease from baseline to six months compared to the HE group (P = .03). Also, the TM group had fewer rehospitalizations during the six months of followup.
CONCLUSIONS: Results indicate that TM can be effective in improving the quality of life and functional capacity of African American CHF patients. Further validation of outcomes is planned via a large, multicenter trial with long-term follow-up.

Entities:  

Mesh:

Year:  2007        PMID: 17274213      PMCID: PMC2048830     

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  35 in total

1.  Clinical criteria and biochemical markers for the detection of systolic dysfunction.

Authors:  K Yamamoto; J C Burnett; E A Bermudez; M Jougasaki; K R Bailey; M M Redfield
Journal:  J Card Fail       Date:  2000-09       Impact factor: 5.712

2.  Racial differences in patients with heart failure.

Authors:  A Afzal; K Ananthasubramaniam; N Sharma; Q al-Malki; A S Ali; G Jacobsen; S M Jafri
Journal:  Clin Cardiol       Date:  1999-12       Impact factor: 2.882

3.  Implementing a congestive heart failure disease management program to decrease length of stay and cost.

Authors:  D Knox; L Mischke
Journal:  J Cardiovasc Nurs       Date:  1999-10       Impact factor: 2.083

4.  Long-term effects of stress reduction on mortality in persons > or = 55 years of age with systemic hypertension.

Authors:  Robert H Schneider; Charles N Alexander; Frank Staggers; Maxwell Rainforth; John W Salerno; Arthur Hartz; Stephen Arndt; Vernon A Barnes; Sanford I Nidich
Journal:  Am J Cardiol       Date:  2005-05-01       Impact factor: 2.778

5.  Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure.

Authors:  W Jiang; J Alexander; E Christopher; M Kuchibhatla; L H Gaulden; M S Cuffe; M A Blazing; C Davenport; R M Califf; R R Krishnan; C M O'Connor
Journal:  Arch Intern Med       Date:  2001 Aug 13-27

Review 6.  Evaluating Health-related quality-of-life outcomes in patients with congestive heart failure. A review of recent randomised controlled trials.

Authors:  N K Leidy; A M Rentz; T M Zyczynski
Journal:  Pharmacoeconomics       Date:  1999-01       Impact factor: 4.981

7.  A community hospital-based congestive heart failure program: impact on length of stay, admission and readmission rates, and cost.

Authors:  R A Rauh; N J Schwabauer; E L Enger; J F Moran
Journal:  Am J Manag Care       Date:  1999-01       Impact factor: 2.229

Review 8.  B-type natriuretic peptide levels: a potential novel "white count" for congestive heart failure.

Authors:  A Maisel
Journal:  J Card Fail       Date:  2001-06       Impact factor: 5.712

9.  Comparison of mental stress-induced myocardial ischemia in coronary artery disease patients with versus without left ventricular dysfunction.

Authors:  Ola Akinboboye; David S Krantz; Willem J Kop; Sari D Schwartz; Joseph Levine; Albert Del Negro; Pamela Karasik; Daniel S Berman; Mark O'Callahan; Karen Ngai; John S Gottdiener
Journal:  Am J Cardiol       Date:  2005-02-01       Impact factor: 2.778

10.  Effects of stress reduction on carotid atherosclerosis in hypertensive African Americans.

Authors:  A Castillo-Richmond; R H Schneider; C N Alexander; R Cook; H Myers; S Nidich; C Haney; M Rainforth; J Salerno
Journal:  Stroke       Date:  2000-03       Impact factor: 10.170

View more
  26 in total

1.  Treatment of fibromyalgia at the Maharishi Ayurveda Health Centre in Norway II--a 24-month follow-up pilot study.

Authors:  Lars Bjørn Rasmussen; Knut Mikkelsen; Margaretha Haugen; Are H Pripp; Jeremy Z Fields; Øystein T Førre
Journal:  Clin Rheumatol       Date:  2012-01-27       Impact factor: 2.980

2.  Mind-body interventions: applications in neurology.

Authors:  Helané Wahbeh; Siegward-M Elsas; Barry S Oken
Journal:  Neurology       Date:  2008-06-10       Impact factor: 9.910

Review 3.  Meditation and coronary heart disease: a review of the current clinical evidence.

Authors:  Indranill Basu Ray; Arthur R Menezes; Pavan Malur; Aimee E Hiltbold; John P Reilly; Carl J Lavie
Journal:  Ochsner J       Date:  2014

Review 4.  A Systematic Review of Relaxation, Meditation, and Guided Imagery Strategies for Symptom Management in Heart Failure.

Authors:  Kristine L Kwekkeboom; Lisa C Bratzke
Journal:  J Cardiovasc Nurs       Date:  2016 Sep-Oct       Impact factor: 2.083

5.  Effect of transcendental meditation on employee stress, depression, and burnout: a randomized controlled study.

Authors:  Charles Elder; Sanford Nidich; Francis Moriarty; Randi Nidich
Journal:  Perm J       Date:  2014

6.  The Relationship Between Focused Attention Meditation Practice Habits, Psychological Symptoms, and Quality of Life.

Authors:  F Isil Bilican
Journal:  J Relig Health       Date:  2016-12

7.  Stress reduction in the secondary prevention of cardiovascular disease: randomized, controlled trial of transcendental meditation and health education in Blacks.

Authors:  Robert H Schneider; Clarence E Grim; Maxwell V Rainforth; Theodore Kotchen; Sanford I Nidich; Carolyn Gaylord-King; John W Salerno; Jane Morley Kotchen; Charles N Alexander
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-11-13

Review 8.  Meditation programs for psychological stress and well-being: a systematic review and meta-analysis.

Authors:  Madhav Goyal; Sonal Singh; Erica M S Sibinga; Neda F Gould; Anastasia Rowland-Seymour; Ritu Sharma; Zackary Berger; Dana Sleicher; David D Maron; Hasan M Shihab; Padmini D Ranasinghe; Shauna Linn; Shonali Saha; Eric B Bass; Jennifer A Haythornthwaite
Journal:  JAMA Intern Med       Date:  2014-03       Impact factor: 21.873

9.  Prevention and Treatment of Cardiovascular Disease in Adolescents and Adults through the Transcendental Meditation(®) Program: A Research Review Update.

Authors:  Vernon A Barnes; David W Orme-Johnson
Journal:  Curr Hypertens Rev       Date:  2012-08

Review 10.  Symptom perception in CHF: (why mind matters).

Authors:  Christine E Skotzko
Journal:  Heart Fail Rev       Date:  2007-12-11       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.